Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene Therapy

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1682-1684
Journal	New England journal of medicine
Volume	377
Issue number	17
Early online date	2017
DOIs	https://doi.org/10.1056/NEJMe1709253
Publication status	Published - 2017

Access to Document

@article{32545dbc25d7429ea8a2edee06c90683,

title = "Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene Therapy",

author = "Marc Engelen",

year = "2017",

doi = "https://doi.org/10.1056/NEJMe1709253",

language = "English",

volume = "377",

pages = "1682--1684",

journal = "New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "17",

}

TY - JOUR

T1 - Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene Therapy

AU - Engelen, Marc

PY - 2017

Y1 - 2017

U2 - https://doi.org/10.1056/NEJMe1709253

DO - https://doi.org/10.1056/NEJMe1709253

M3 - Editorial

C2 - 28976819

SN - 0028-4793

VL - 377

SP - 1682

EP - 1684

JO - New England journal of medicine

JF - New England journal of medicine

IS - 17

ER -